CXCR4 and acute myeloid leukemia: Overexpressed on AML LSCs, mediating bone marrow niche retention and promoting survival. Associated with poor prognosis. Blockade of CXCR4 mobilizes LSCs into circulation, which may increase their susceptibility to chemotherapy. Also expressed on normal HSCs, which limits specificity